Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Hajjar

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Nature Clinical Practice. Cardiovascular Medicine|November 22, 2008
Cardiac cell and gene therapies: two trajectories, one goalRoger Hajjar, Valentin Fuster
Journal of Molecular and Cellular Cardiology|April 8, 2006
Modulation of action potential duration on myocyte hypertrophic pathwaysDjamel Lebeche, Roger Kaprielian, Roger Hajjar
Journal of Molecular Medicine (Berlin, Germany)|June 20, 2002
Molecular components of transient outward potassium current in cultured neonatal rat ventricular myocytesZamaneh Kassiri, Roger Hajjar, Peter H Backx
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|January 18, 2017
Candesartan abrogates G protein-coupled receptors agonist-induced MAPK activation and cardiac myocyte hypertrophyDjamel Lebeche, Zhao Bin Kang, Roger Hajjar
Science of Aging Knowledge Environment : SAGE KE|July 8, 2003
Telomerase and the aging heartE Kevin Heist, Fawzia Huq, Roger Hajjar
Clinical Chemistry|September 24, 2011
Clopidogrel and CYP2C19 testing: ready for clinical prime time?Jean-Sébastien Hulot, Roger Hajjar, Gilles Montalescot
Cardiovascular Research|February 24, 2010
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failureWolfgang Poller, Roger Hajjar, Heinz-Peter Schultheiss, et al.
Cells|November 24, 2023
Exploration of the Noncoding Genome for Human-Specific Therapeutic Targets-Recent Insights at Molecular and Cellular LevelWolfgang Poller, Susmita Sahoo, Roger Hajjar, et al.
Journal of Translational Medicine|August 13, 2011
SERCA2a gene transfer improves electrocardiographic performance in aged mdx miceJin-Hong Shin, Brian Bostick, Yongping Yue, et al.
Cardiovascular Drugs and Therapy|June 24, 2017
Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 DiabetesNadjib Hammoudi, Dongtak Jeong, Rajvir Singh, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Nature Clinical Practice. Cardiovascular Medicine|November 22, 2008
Cardiac cell and gene therapies: two trajectories, one goalRoger Hajjar, Valentin Fuster
Journal of Molecular and Cellular Cardiology|April 8, 2006
Modulation of action potential duration on myocyte hypertrophic pathwaysDjamel Lebeche, Roger Kaprielian, Roger Hajjar
Journal of Molecular Medicine (Berlin, Germany)|June 20, 2002
Molecular components of transient outward potassium current in cultured neonatal rat ventricular myocytesZamaneh Kassiri, Roger Hajjar, Peter H Backx
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|January 18, 2017
Candesartan abrogates G protein-coupled receptors agonist-induced MAPK activation and cardiac myocyte hypertrophyDjamel Lebeche, Zhao Bin Kang, Roger Hajjar
Science of Aging Knowledge Environment : SAGE KE|July 8, 2003
Telomerase and the aging heartE Kevin Heist, Fawzia Huq, Roger Hajjar
Clinical Chemistry|September 24, 2011
Clopidogrel and CYP2C19 testing: ready for clinical prime time?Jean-Sébastien Hulot, Roger Hajjar, Gilles Montalescot
Cardiovascular Research|February 24, 2010
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failureWolfgang Poller, Roger Hajjar, Heinz-Peter Schultheiss, et al.
Cells|November 24, 2023
Exploration of the Noncoding Genome for Human-Specific Therapeutic Targets-Recent Insights at Molecular and Cellular LevelWolfgang Poller, Susmita Sahoo, Roger Hajjar, et al.
Journal of Translational Medicine|August 13, 2011
SERCA2a gene transfer improves electrocardiographic performance in aged mdx miceJin-Hong Shin, Brian Bostick, Yongping Yue, et al.
Cardiovascular Drugs and Therapy|June 24, 2017
Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 DiabetesNadjib Hammoudi, Dongtak Jeong, Rajvir Singh, et al.
Pageof 4